Leap Therapeutics (LPTX) News Today

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

$2.96

-0.04 (-1.33%)

(As of 04/18/2024 ET)

Source

Source	Headline
	Leap Therapeutics (NASDAQ:LPTX) Trading 4% Higher americanbankingnews.com - April 14 at 6:06 AM
	Leap Therapeutics To Sell $40 Mln Of Shares In Private Placement; Stock Up Over 14% markets.businessinsider.com - April 11 at 4:11 PM
	Leap Therapeutics Announces $40 Million Private Placement prnewswire.com - April 11 at 8:30 AM
	5 Best Biotech Penny Stocks to Invest In insidermonkey.com - March 26 at 2:16 PM
	Q1 2024 Earnings Estimate for Leap Therapeutics, Inc. Issued By HC Wainwright (NASDAQ:LPTX) marketbeat.com - March 21 at 8:02 AM
	Leap Therapeutics: Promising Clinical Outcomes and Upcoming Catalysts Bolster Buy Rating markets.businessinsider.com - March 19 at 4:28 PM
	Leap Therapeutics (NASDAQ:LPTX) Rating Reiterated by HC Wainwright marketbeat.com - March 19 at 8:34 AM
	Leap Therapeutics (NASDAQ:LPTX) Price Target Cut to $9.00 marketbeat.com - March 19 at 8:34 AM
	LPTX Stock Earnings: Leap Therapeutics Beats EPS for Q4 2023 investorplace.com - March 18 at 5:07 PM
	Leap Therapeutics, Inc.: Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results finanznachrichten.de - March 18 at 10:23 AM
	Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results finance.yahoo.com - March 18 at 10:23 AM
	LPTX Apr 2024 5.000 call finance.yahoo.com - March 15 at 2:47 AM
	Acuta Capital Partners LLC Purchases New Shares in Leap Therapeutics, Inc. (NASDAQ:LPTX) marketbeat.com - March 3 at 12:18 PM
	683 Capital Management LLC Has $676,000 Stock Position in Leap Therapeutics, Inc. (NASDAQ:LPTX) marketbeat.com - March 1 at 10:36 AM
	LPTX Mar 2024 7.000 call finance.yahoo.com - February 17 at 8:46 AM
	Leap Therapeutics, Inc. (NASDAQ:LPTX) Short Interest Update marketbeat.com - January 31 at 5:35 AM
	Outperform Rating on Leap Therapeutics Amid Promising Gastric Cancer Trial Outcomes markets.businessinsider.com - January 26 at 7:23 AM
	Evolus, Leap Therapeutics among healthcare movers msn.com - January 17 at 3:15 PM
	Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium finance.yahoo.com - January 16 at 6:35 PM
	Optimism High as Leap Therapeutics’ Studies Suggest Potential for Significant Shareholder Value markets.businessinsider.com - January 6 at 10:15 AM
	LPTX Jun 2024 1.000 call ca.finance.yahoo.com - January 4 at 7:55 PM
	LPTX Mar 2024 1.000 call ca.finance.yahoo.com - January 4 at 7:55 PM
	Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference finance.yahoo.com - January 3 at 7:53 AM
	Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients finance.yahoo.com - January 2 at 10:32 AM
	Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers Symposium finance.yahoo.com - December 11 at 6:52 PM
	Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference finance.yahoo.com - November 21 at 7:52 AM
	Raymond James Maintains Outperform Rating for Leap Therapeutics: Here's What You Need To Know markets.businessinsider.com - November 14 at 2:08 PM
	Leap Therapeutics, Inc.: Leap Therapeutics Reports Third Quarter 2023 Financial Results finanznachrichten.de - November 13 at 9:31 AM
	Recap: Leap Therapeutics Q3 Earnings benzinga.com - November 13 at 9:31 AM
	Leap Therapeutics Reports Third Quarter 2023 Financial Results finance.yahoo.com - November 13 at 9:31 AM
	Leap Therapeutics to Participate at Upcoming Investor Conferences finance.yahoo.com - September 5 at 6:06 PM
	HC Wainwright & Co. Maintains Leap Therapeutics (LPTX) Buy Recommendation msn.com - August 15 at 6:09 PM
	Baird Maintains Leap Therapeutics (LPTX) Outperform Recommendation msn.com - August 15 at 6:09 PM
	Leap Therapeutics (LPTX) Receives a Buy from H.C. Wainwright markets.businessinsider.com - August 15 at 7:59 AM
	Leap Therapeutics, Inc.: Leap Therapeutics Reports Second Quarter 2023 Financial Results finanznachrichten.de - August 14 at 4:53 PM
	Leap Therapeutics Reports Second Quarter 2023 Financial Results finance.yahoo.com - August 14 at 4:53 PM
	Raymond James Maintains Leap Therapeutics (LPTX) Outperform Recommendation msn.com - July 14 at 12:41 AM
	Leap Therapeutics Announces Initiation of Randomized Controlled Part B of the DeFianCe Study of DKN-01 in Colorectal Cancer Patients finance.yahoo.com - July 12 at 9:07 AM
	Leap Therapeutics (LPTX) Price Target Increased by 876.00% to 24.89 msn.com - July 6 at 11:33 PM
	Leap Therapeutics (LPTX) Receives a Buy from Raymond James markets.businessinsider.com - June 23 at 12:27 PM
	Leap Therapeutics (NASDAQ:LPTX) Given New $17.00 Price Target at Raymond James marketbeat.com - June 23 at 9:08 AM
	8-K: LEAP THERAPEUTICS, INC. marketwatch.com - June 22 at 3:37 PM
	Leap Therapeutics, Inc.: Leap Therapeutics Announces Reverse Stock Split finanznachrichten.de - June 21 at 8:14 AM
	Leap Therapeutics Announces Reverse Stock Split finance.yahoo.com - June 20 at 2:45 PM
	Robert W. Baird Sticks to Their Buy Rating for Leap Therapeutics (LPTX) markets.businessinsider.com - May 29 at 3:34 PM
	Leap Therapeutics (LPTX) Receives a Buy from Mizuho Securities markets.businessinsider.com - May 26 at 2:13 AM
	HC Wainwright & Co. Reiterates Leap Therapeutics (LPTX) Buy Recommendation msn.com - May 16 at 9:31 PM
	H.C. Wainwright Sticks to Its Buy Rating for Leap Therapeutics (LPTX) markets.businessinsider.com - May 16 at 9:33 AM
	Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Leap Therapeutics (LPTX) and Jasper Therapeutics (JSPR) markets.businessinsider.com - May 15 at 3:04 PM
	Leap Therapeutics Reports First Quarter 2023 Financial Results finance.yahoo.com - May 15 at 10:03 AM

Get Leap Therapeutics News Delivered to You Automatically

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

LPTX Media Mentions By Week

LPTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LPTX
News Sentiment
▼
0.39

0.50
▲
Average
Medical
News Sentiment

LPTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LPTX Articles
This Week
▼
1

1
▲
LPTX Articles
Average Week

Get Leap Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:LPTX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Leap Therapeutics (LPTX) News Today

LPTX Media Mentions By Week

LPTX Media Sentiment

LPTX News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info